Exagen Inc. (NASDAQ: XGN) reported Q1 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $14.66 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.